John G Ullman & Associates Inc. Increases Position in Encompass Health Corporation $EHC

John G Ullman & Associates Inc. increased its position in shares of Encompass Health Corporation (NYSE:EHC) by 47.2% during the 1st quarter, Holdings Channel reports. The firm owned 40,400 shares of the company’s stock after acquiring an additional 12,950 shares during the period. John G Ullman & Associates Inc.’s holdings in Encompass Health were worth $3,908,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. boosted its holdings in Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after buying an additional 3,793,358 shares during the period. Norges Bank bought a new stake in Encompass Health during the fourth quarter valued at about $133,221,000. Price T Rowe Associates Inc. MD lifted its position in shares of Encompass Health by 24.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock valued at $510,047,000 after acquiring an additional 948,202 shares in the last quarter. Millennium Management LLC boosted its stake in shares of Encompass Health by 140.0% in the third quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock worth $155,430,000 after acquiring an additional 713,738 shares during the period. Finally, 8 Knots Management LLC bought a new position in shares of Encompass Health in the second quarter worth about $78,644,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling at Encompass Health

In related news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Weiss Ratings downgraded Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. TD Cowen assumed coverage on Encompass Health in a research note on Thursday, May 28th. They issued a “buy” rating and a $125.00 price target for the company. Barclays cut their price objective on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Leerink Partners set a $152.00 target price on shares of Encompass Health in a report on Friday, May 22nd. Finally, Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $143.86.

Encompass Health Trading Down 0.2%

Shares of EHC stock opened at $112.24 on Friday. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The stock has a market capitalization of $11.13 billion, a price-to-earnings ratio of 18.74, a price-to-earnings-growth ratio of 2.45 and a beta of 0.74. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The stock’s 50-day moving average price is $104.47 and its 200-day moving average price is $103.62.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm’s revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities research analysts predict that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st were given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, July 1st. Encompass Health’s dividend payout ratio is currently 12.69%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.